Importance Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory
disease of the esophagus that affects an estimated 34.4/100 000 people in Europe and …

Background The frequency of eosinophilic oesophagitis (EoE) occurrence is escalating.
Current diagnostic criteria recently proposed for the disease, determine that previous …

Background Benralizumab is an eosinophil-depleting anti–interleukin-5 receptor α
monoclonal antibody. The efficacy and safety of benralizumab in patients with eosinophilic …

Background Empirical elimination diets are effective for achieving histological remission in
eosinophilic oesophagitis, but randomised trials comparing diet therapies are lacking. We …

Association (AGA) and the Joint Task Force on Allergy-Immunology Practice Parameters
(JTF) on the management of eosinophilic esophagitis. The guideline was developed jointly …

Background Eosinophilic oesophagitis (EoE) is an increasingly common cause of dysphagia
in both children and adults, as well as one of the most prevalent oesophageal diseases with …

Background & Aims Disease activity and severity of eosinophilic esophagitis (EoE) dictate
therapeutic options and management, but the decision-making process for determining …

Background & Aims Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder.
Swallowed topical-acting corticosteroids are effective in bringing active EoE into remission …

Food allergies are the result of immune responses that cause adverse reactions to foods.
Immune responses to foods may produce a spectrum of symptoms and disorders, including …

Up to 40% of patients with symptoms suspicious of gastroesophageal reflux disease (GERD)
do not respond completely to proton pump inhibitor (PPI) therapy. The term “refractory …